FDA Warns Diabetics Taking Invokana – Amputation is a Risk!
Filed in: Invokana
Filed in: Invokana
Team, T. (2017, May 18). Understanding J&J's risk from new FDA label warning for Invokana. Retrieved from https://www.forbes.com/sites/greatspeculations/2017/05/18/understanding-jjs-risk-from-new-fda-label-warning-for-invokana/#180b4d57c795
FDA confirms increased risk of leg and foot amputations with the diabetes medicine canagliflozin (Invokana, Invokamet, Invokamet XR). (2017). FDA Drug Safety Communications, 1-5. doi:https://www.fda.gov/downloads/Drugs/DrugSafety/UCM558427.pdf